From With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?:

Jeff Tong
Jeff Tong—

Jeff Tong is the CEO of Ambys Medicines and a venture partner at Third Rock Ventures. Photo courtesy of Tri Nguyen/Ambys Medicines

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

© 2007-2021, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.